SEC 13F Intelligence

Zebra Capital Management LLC / ACAD

Zebra Capital Management LLC’s Acadia Pharmaceuticals Inc Position

Does Zebra Capital Management LLC own Acadia Pharmaceuticals Inc (ACAD)? Yes — 11.6K shares worth $218,000 (+1.09% of its 13F portfolio) as of Q1 2023, down from 14.6K shares the prior filed quarter.

Position Value
$218,000
Q1 2023
Shares
11.6K
% of Portfolio
+1.09%
Quarters Held
6
currently held

Position History ACAD

Reported value by quarter
Q3 ’21: $455,000Q3 ’21Q4 ’21: $468,000Q4 ’21Q1 ’22: $244,000Q1 ’22Q3 ’22: $221,000Q3 ’22Q4 ’22: $233,000Q4 ’22Q1 ’23: $218,000Q1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202311.6K$218,000+1.09%
Q4 202214.6K$233,000+0.82%
Q3 202213.5K$221,000+0.84%
Q1 202210.1K$244,000+0.56%
Q4 202120.0K$468,000+0.75%
Q3 202127.4K$455,000+0.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Zebra Capital Management LLC’s full portfolio or all institutional holders of ACAD.